Literature DB >> 15976816

Ageing and metabolism: drug discovery opportunities.

Rory Curtis1, Bard J Geesaman, Peter S DiStefano.   

Abstract

There has recently been significant progress in our understanding of the mechanisms that regulate ageing, and it has been shown that changes in single genes can dramatically extend lifespan and increase resistance to many diseases. Furthermore, many of these genes belong to evolutionarily conserved pathways that also control energy metabolism. In this review, we describe the shared molecular machinery that regulates ageing and energy metabolism. Although drugs to slow ageing face severe regulatory hurdles, it is likely that an understanding of ageing pathways will help to identify novel drug targets to treat metabolic disorders and other age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976816     DOI: 10.1038/nrd1777

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  26 in total

1.  Pharmacologic induction of CD8+ T cell memory: better living through chemistry.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Sci Transl Med       Date:  2009-12-16       Impact factor: 17.956

2.  Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats.

Authors:  Tristano Pancani; Katie L Anderson; Lawrence D Brewer; Inga Kadish; Chris DeMoll; Philip W Landfield; Eric M Blalock; Nada M Porter; Olivier Thibault
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

3.  Aging and the Mammalian regulatory triumvirate.

Authors:  C David Rollo
Journal:  Aging Dis       Date:  2010-09-10       Impact factor: 6.745

Review 4.  Age, APOE and sex: Triad of risk of Alzheimer's disease.

Authors:  Brandalyn C Riedel; Paul M Thompson; Roberta Diaz Brinton
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-08       Impact factor: 4.292

5.  Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications.

Authors:  Amélie Bonnefond; Boris Skrobek; Stéphane Lobbens; Elodie Eury; Dorothée Thuillier; Stéphane Cauchi; Olivier Lantieri; Beverley Balkau; Elio Riboli; Michel Marre; Guillaume Charpentier; Loïc Yengo; Philippe Froguel
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

6.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

7.  Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE).

Authors:  Sharda P Singh; Maciej Niemczyk; Ludwika Zimniak; Piotr Zimniak
Journal:  Aging (Albany NY)       Date:  2008-12-18       Impact factor: 5.682

Review 8.  Validation of anti-aging drugs by treating age-related diseases.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-03-28       Impact factor: 5.682

9.  Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2010-05       Impact factor: 5.682

Review 10.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Authors:  Olivier Thibault; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Philip W Landfield; Nada M Porter
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.